1. Home
  2. XLO vs RAYA Comparison

XLO vs RAYA Comparison

Compare XLO & RAYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XLO
  • RAYA
  • Stock Information
  • Founded
  • XLO 2016
  • RAYA 2019
  • Country
  • XLO United States
  • RAYA China
  • Employees
  • XLO N/A
  • RAYA N/A
  • Industry
  • XLO Biotechnology: Pharmaceutical Preparations
  • RAYA Metal Fabrications
  • Sector
  • XLO Health Care
  • RAYA Consumer Discretionary
  • Exchange
  • XLO Nasdaq
  • RAYA Nasdaq
  • Market Cap
  • XLO 42.1M
  • RAYA 35.8M
  • IPO Year
  • XLO 2021
  • RAYA 2022
  • Fundamental
  • Price
  • XLO $0.83
  • RAYA $1.35
  • Analyst Decision
  • XLO Buy
  • RAYA
  • Analyst Count
  • XLO 1
  • RAYA 0
  • Target Price
  • XLO $4.00
  • RAYA N/A
  • AVG Volume (30 Days)
  • XLO 592.2K
  • RAYA 23.5K
  • Earning Date
  • XLO 11-07-2024
  • RAYA 01-01-0001
  • Dividend Yield
  • XLO N/A
  • RAYA N/A
  • EPS Growth
  • XLO N/A
  • RAYA N/A
  • EPS
  • XLO N/A
  • RAYA N/A
  • Revenue
  • XLO $4,620,000.00
  • RAYA $22,816,585.00
  • Revenue This Year
  • XLO N/A
  • RAYA $64.53
  • Revenue Next Year
  • XLO $368.76
  • RAYA $9.61
  • P/E Ratio
  • XLO N/A
  • RAYA N/A
  • Revenue Growth
  • XLO N/A
  • RAYA N/A
  • 52 Week Low
  • XLO $0.50
  • RAYA $0.50
  • 52 Week High
  • XLO $1.93
  • RAYA $1.78
  • Technical
  • Relative Strength Index (RSI)
  • XLO 39.23
  • RAYA 57.01
  • Support Level
  • XLO $0.78
  • RAYA $1.15
  • Resistance Level
  • XLO $1.28
  • RAYA $1.47
  • Average True Range (ATR)
  • XLO 0.13
  • RAYA 0.15
  • MACD
  • XLO -0.02
  • RAYA -0.00
  • Stochastic Oscillator
  • XLO 9.94
  • RAYA 62.86

About XLO Xilio Therapeutics Inc.

Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies (including bispecifics) and immune cell engagers (including tumor-activated cell engagers and tumor-activated effector-enhanced cell engagers).

About RAYA Erayak Power Solution Group Inc.

Erayak Power Solution Group Inc engages in manufacturing, research and development, and wholesale and retail of power solution products. Its product portfolio includes sine wave and off-grid inverters, inverter and gasoline generators, battery, and smart chargers, and custom-designed products. It derives the majority revenue from three products namely inverters, chargers, and gasoline generators. The company geographically operates in China, Australia, Poland, U.K., and Germany. It derives maximum revenue from China.

Share on Social Networks: